−740 KRW
−10.42 B KRW
4.03 B KRW
5.44 M
About IMBDX, INC.
Sector
Industry
Headquarters
Seoul
Website
Founded
2018
ISIN
KR7461030009
FIGI
BBG01LCGCWD5
IMBdx, Inc. engages in the development of liquid biopsy tests for cancer diagnosis. It focuses on the following business areas: diagnosis and treatment of advanced cancer, early detection of recurrence after surgery, and early cancer diagnosis. Its products include AlphaLiquid, CancerDetect, and CancerFind. The company was founded by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 461030 is 10,700 KRW — it has decreased by −7.68% in the past 24 hours. Watch IMBDX, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange IMBDX, INC. stocks are traded under the ticker 461030.
461030 stock has risen by 0.19% compared to the previous week, the month change is a −7.76% fall, over the last year IMBDX, INC. has showed a −62.52% decrease.
461030 reached its all-time high on Apr 3, 2024 with the price of 40,550 KRW, and its all-time low was 8,430 KRW and was reached on Jul 10, 2024. View more price dynamics on 461030 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
461030 stock is 9.35% volatile and has beta coefficient of −0.51. Track IMBDX, INC. stock price on the chart and check out the list of the most volatile stocks — is IMBDX, INC. there?
Today IMBDX, INC. has the market capitalization of 149.99 B, it has increased by 13.46% over the last week.
Yes, you can track IMBDX, INC. financials in yearly and quarterly reports right on TradingView.
461030 net income for the last quarter is −2.29 B KRW, while the quarter before that showed −2.30 B KRW of net income which accounts for 0.33% change. Track more IMBDX, INC. financial stats to get the full picture.
No, 461030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 56.00 employees. See our rating of the largest employees — is IMBDX, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMBDX, INC. EBITDA is −9.37 B KRW, and current EBITDA margin is −151.98%. See more stats in IMBDX, INC. financial statements.
Like other stocks, 461030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMBDX, INC. stock right from TradingView charts — choose your broker and connect to your account.